Sonara Health
Dallas, US · Founded 2020 · Delaware corporation · 2 known investors
Sonara provides a hybrid care model for opioid treatment programs that combines at-home medication management with remote monitoring and clinical oversight. The platform enables patients to take methadone at home while maintaining secure connection to care teams, designed to expand treatment access while reducing barriers to adherence.
Founders & leadership
MG
Michael GilesChief Executive Officer
DR
DANIEL R. KARLINDirector
JG
JUSTIN GELLERExecutive Officer
RK
RACHEL KERNDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4.7MraisedMay 2025 · 11 investors · Other Health CareRule 506(b)
▶$4.7MraisedMay 2025 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL R. KARLINDirector
- MICHAEL GILESExecutive Officer, Director
- JUSTIN GELLERExecutive Officer
- RACHEL KERNDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.3MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
▶$2.3MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL R. KARLINDirector
- RACHEL KERNDirector
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.3M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.3MraisedSep 2022 · 19 investors · Other Health CareRule 506(b)
▶$1.3MraisedSep 2022 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$550KraisedSep 2022 · 17 investors · Other Health CareRule 506(b)
▶$550KraisedSep 2022 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $550K
- Amount sold
- $550K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Boomerang Ventures Invests $1M in Sonara Health to Scale Hybrid Methadone Care Nationwideboomerang.vc · 2025
- Sonara Health Receives $2.5M Grant from NIDA and Funding Allocation from New Jersey | Sonara Healthsonarahealth.com · 2024
- Mark Cuban-Backed Opioid Recovery Startup Sonara Health Raises $3M for Medication Monitoring Platform » Dallas Innovatesdallasinnovates.com · 2022
- Sonara Health Raises $3M in Seed Fundingfinsmes.com · 2022
- Sonara Health raises $3M for digital methadone management platform | MobiHealthNewsmobihealthnews.com · 2022
- Sonara Health Raises $3 Million to Fight the Opioid Crisis, Bringing Total Funding to Over $5 Millionprnewswire.com · 2022